The Trump administration's termination of federal research grants earlier this year disrupted about 1 in 30 clinical trials funded by the National Institutes of Health, new research shows.

Why it matters: More than 74,000 patients were enrolled in the interrupted trials. • "There's a commitment that patients make to the clinical trials ... Here, you've broken a commitment to those individuals," Anupam Jena, an author of the study and a professor at Harvard Medical School, told Axios. • The funding cuts raise concerns about avoidable waste, data quality and ethical obligations to patients, the study published published Monday in JAMA Internal Medicine says.

Catch up quick: NIH cut some $3.8 billion in grant funding to U.S. institutions earlier this year. Many of those grants were to s

See Full Page